Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry

NCT04688190 is registered in ClinicalTrials.gov with Universitätsklinikum Hamburg-Eppendorf as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04688190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2020
Completion date
December 31, 2030
Enrollment
1,000 (estimated)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

mitral annular calcification, mitral regurgitation, mitral valve disease